Sugi Predict

Sugi Predict / Compounds / SCHEMBL892786

SCHEMBL892786

SCHEMBL892786

O=C(O)Cc1ccc(F)cc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.53
▸ POLQ O75417 3/20 0.49
▸ TSHR P16473 1/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ RXRA P19793 3/20 0.47
▸ RXRB P28702 3/20 0.47
▸ RXRG P48443 3/20 0.47
▸ PTGDR2 Q9Y5Y4 1/20 0.46
▸ P2RX7 Q99572 6/20 0.45
▸ PTGS2 P35354 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL154096 0.86 RXRA (0.49) IDO1POLQTSHRRXRARXRB
SCHEMBL20844648 0.84 TSHR (0.46) POLQTSHRRXRARXRBRXRG
SCHEMBL20818326 0.84 IDO1 (0.51) IDO1POLQHDAC3HDAC1HDAC2
SCHEMBL1508573 0.83 FFAR4 (0.54) IDO1HDAC3HDAC1HDAC2HDAC6
SCHEMBL14793818 0.82 CAMK2A (0.47) POLQTSHRRXRARXRBRXRG
SCHEMBL30716953 0.82 POLQ (0.61) POLQRXRARXRBRXRGPTGDR2
SCHEMBL3741058 0.82 POLQ (0.61) POLQRXRARXRBRXRGPTGDR2
SCHEMBL29010092 0.81 IDO1 (0.49) IDO1HDAC3HDAC1HDAC2HDAC6
SCHEMBL20563511 0.81 RXRA (0.46) POLQRXRARXRBRXRGPTGDR2
SCHEMBL2728649 0.81 GLA (0.48) POLQTSHRRXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108529988-B Impervious concrete for shield segment and preparation method thereof 北京港创瑞博混凝土有限公司 2020-12-01 — — CN claimed
CN-108529988-A Shield duct piece water-tight concrete and preparation method thereof 北京港创瑞博混凝土有限公司 2018-09-14 — — CN claimed
CN-112830727-A Anti-erosion and anti-corrosion concrete shield segment 南通铁建建设构件有限公司 2021-05-25 — — CN disclosed
CN-108529988-B Impervious concrete for shield segment and preparation method thereof 北京港创瑞博混凝土有限公司 2020-12-01 — — CN disclosed
EP-3190109-B1 INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIV LEUVEN KATH (BE) 2020-02-19 — — EP disclosed
US-20190054068-A1 Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases REMYND (BE) 2019-02-21 — — US disclosed
US-20190031599-A1 INDANE DERIVATIVES AS MGLUR7 MODULATORS TAKEDA CAMBRIDGE LIMITED (GB) 2019-01-31 — — US disclosed
US-20190031599-A1 INDANE DERIVATIVES AS MGLUR7 MODULATORS TAKEDA CAMBRIDGE LIMITED (GB) 2019-01-31 — — US disclosed
EP-3408256-A1 INDANE DERIVATIVES AS MGLUR7 MODULATORS Takeda Pharmaceutical Company Limited (JP) 2018-12-05 — — EP disclosed
US-10117850-B2 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2018-11-06 — — US disclosed
CN-108529988-A Shield duct piece water-tight concrete and preparation method thereof 北京港创瑞博混凝土有限公司 2018-09-14 — — CN disclosed
US-7700597-B2 Substituted piperazines as CB1 antagonists SCHERING CORPORATION (US) 2010-04-20 — — US disclosed
WO-2010031183-A1 INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS MERCK FROSST CANADA LTD. (CA) 2010-03-25 — — WO disclosed
US-20100029607-A1 Substituted Piperazines as CB1 Antagonists SCHERING CORPORATION 2010-02-04 — — US disclosed
US-20100029607-A1 Substituted Piperazines as CB1 Antagonists SCHERING CORPORATION 2010-02-04 — — US disclosed
EP-2148865-A1 PYRAZOLE INHIBITORS OF WNT SIGNALING Genentech, Inc. (US) 2010-02-03 — — EP disclosed
WO-2009108332-A1 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-09-03 — — WO disclosed
US-20090093464-A1 Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor SMITHKLINE BEECHMA CORPORATION (US) 2009-04-09 — — US disclosed
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS EISAI R&D MANAGEMENT CO., LTD., (JP) 2009-03-05 — — US disclosed
WO-2008137408-A1 PYRAZOLE INHIBITORS OF WNT SIGNALING GENENTECH, INC. (US) 2008-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190054068-A1 Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases SNCA, MAPT, NLN IDO1 9/4885POLQ 4325/4885TSHR 4264/4885
US-10117850-B2 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases SNCA, MAPT, NLN IDO1 9/4885POLQ 4336/4885TSHR 4280/4885
US-20100029607-A1 Substituted Piperazines as CB1 Antagonists CNR1, CNR2, GPR119 IDO1 1984/4885POLQ 3715/4885TSHR 913/4885
US-20190031599-A1 INDANE DERIVATIVES AS MGLUR7 MODULATORS GRM7, GRIN2B, GRM1 IDO1 617/4885POLQ 4880/4885TSHR 343/4885
US-20090093464-A1 Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor NR3C1, NR3C2, NR5A1 IDO1 2099/4885POLQ 4245/4885TSHR 338/4885
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS APP, BACE1, PSEN1 IDO1 716/4885POLQ 3027/4885TSHR 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.